Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Pexidartinib |
| Trade Name | Turalio |
| Synonyms | PLX3397|CML-261 |
| Drug Descriptions |
Turalio (pexidartinib) inhibits multiple receptor tyrosine kinases, including KIT, CSF1R, FLT3, and FLT3/ITD, which may inhibit growth in cancer cells (PMID: 22294205, PMID: 25993548, PMID: 25847190). Turalio (pexidartinib) is FDA approved for use in patients with symptomatic tenosynovial giant cell tumor (FDA.gov). |
| DrugClasses | CSF1R Inhibitor 28 FLT3 Inhibitor 69 KIT Inhibitor 57 |
| CAS Registry Number | 1029044-16-3 |
| NCIT ID | C88303 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Binimetinib + Pexidartinib | Binimetinib Pexidartinib | 0 | 1 |
| Paclitaxel + Pexidartinib | Paclitaxel Pexidartinib | 0 | 1 |
| Palbociclib + Pexidartinib | Palbociclib Pexidartinib | 0 | 0 |
| Pembrolizumab + Pexidartinib | Pembrolizumab Pexidartinib | 0 | 1 |
| Pexidartinib | Pexidartinib | 54 | 7 |
| Pexidartinib + PLX9486 | PLX9486 Pexidartinib | 2 | 1 |
| Pexidartinib + Samuraciclib | Pexidartinib Samuraciclib | 0 | 0 |
| Pexidartinib + Sirolimus | Pexidartinib Sirolimus | 0 | 1 |
| Pexidartinib + Vemurafenib | Pexidartinib Vemurafenib | 0 | 1 |
| Pexidartinib + VIP152 | Pexidartinib VIP152 | 0 | 0 |